Malaysian-adapted Asian Crohn's disease diet

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled project develops and tests a culturally appropriate Asian version of the Crohn's Disease Exclusion Diet (CDED) for patients at Universiti Malaya Medical Centre. The study includes in-depth interviews to refine diet acceptability, a controlled dietary intervention comparing the modified CDED with a general healthy diet, and microbiome analysis to identify changes after the diet. Participants with confirmed mild-to-moderate Crohn's disease are followed for 24 weeks with visits at 0, 6, 12, and 24 weeks, providing stool and blood samples for clinical, biochemical, and microbiome assessments. Outcomes will include clinical disease activity scores and shifts in gut microbial composition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Confirmed diagnosis of Crohn's disease according to established clinical, endoscopic, and histological criteria.
* Mild to moderate diseases (150 to 220 points).
* Written informed consent obtained.

Exclusion Criteria:

* Presence of stoma.
* Surgery within 6 months prior to randomization.
* Patient on exclusive enteral nutrition (EEN).

Where it's running

• Universiti Malaya Medical Centre
  Kuala Lumpur, Petaling Jaya, Malaysia Recruiting

Study contacts

• Study coordinator: Ida Normiha Hilmi, MRCP PhD
• Email: ida@ummc.edu.my
• Phone: 0379492868

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Microencapsulated Propionate vs Butyrate for Crohn's Disease in Remission

  This study tests whether microencapsulated sodium propionate can favorably alter the gut microbiota and inflammation in adults with Crohn’s disease, compared with sodium butyrate.

  Recruiting University of Padova · Padova · NCT07883044

• Risankizumab for Refractory Perianal Fistulizing Crohn's Disease

  This study tests whether risankizumab can help people with Crohn’s disease who have draining perianal fistulas not responding to other treatments.

  Recruiting Phase 4 Hyogo Medical University · Nishinomiya and 3 other locations · NCT07872449

• Intestinal ultrasound-guided management for inflammatory bowel disease

  This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.

  Recruiting Mahidol University · Bangkok · NCT07775352

• Laser-based sizing of GI lesions during endoscopies

  This study tests whether the AccuMeasure laser tool gives more accurate and reliable lesion size measurements during colonoscopies for adults with colon polyps or Crohn’s disease than traditional endoscopic estimates.

  Recruiting Centre hospitalier de l'Université de Montréal (CHUM) · Montreal, Quebec · NCT07770425

• A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis

  A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.

  Recruiting Catholic University of the Sacred Heart · Roma, RM · NCT07724990

• Claudin-2 Immunostaining to Detect Active or Inactive Inflammation in IBD Biopsies

  This study tests whether staining for Claudin-2 in intestinal biopsy samples can help identify active vs. inactive inflammation in people with ulcerative colitis or Crohn's disease.

  Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Mi · NCT07710287

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.